GRI Bio GRI
NASDAQ GRI
$1.96 +0.03 (+1.55%)
At close: Oct 1, 2026 · 4:00 PM EDT

GRI Bio (GRI) Other Non-Current Assets (2020 - 2022)

Updated

GRI Bio's Other Non-Current Assets came in at $169,000 for Q2 2022, down 30.5% from $243,000 a year earlier and down 9.6% from the prior quarter.

Analysis

GRI Bio (GRI) Other Non-Current Assets (2020 - 2022) Analysis & Trends

At the end of FY2021, GRI Bio's Other Non-Current Assets was $206,000, down 26.2% from FY2020.

  • Going back by year, Other Non-Current Assets was $279,000 in FY2020.
  • Business Quant data shows GRI's Other Non-Current Assets at $187,000 (Q1 2022), $206,000 (Q4 2021) and $224,000 (Q3 2021) in the three quarters before Q2 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 14.27 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 10.73 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 19.60 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 5.93 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 12.98 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 4.75 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 9.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.25 Bn
10 GRI Bio 3.48 Mn 3.48 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 169,000.00
Mar 31, 2022 187,000.00
Dec 31, 2021 206,000.00
Sep 30, 2021 224,000.00
Jun 30, 2021 243,000.00
Dec 31, 2020 279,000.00
API Access

GRI Bio Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=GRI&period=max&api_key=YOUR_API_KEY